Vanda Pharmaceuticals does not manufacture a single medication named "Vanda"; rather, the company develops and commercializes a portfolio of specialized prescription drugs targeting central nervous system (CNS) disorders and rare medical conditions. Its flagship commercial products include Fanapt (iloperidone) for schizophrenia and Hetlioz (tasimelteon) for non-24-hour sleep-wake disorder and nighttime sleep disturbances in Smith-Magenis syndrome.